Skip to main content
Fig. 2 | Pediatric Rheumatology

Fig. 2

From: Case report: novel NFKB2 variant associated with pediatric eosinophilic granulomatosis with polyangiitis (EGPA) in the COVID-19 pandemic

Fig. 2

Hematologic and genetic studies. a WBC, CRP, neutrophils and EOS during treatment; b Subcutaneous nodules on the patient’s right cheek and bilateral lower leg. c Illustration of the location of the patient's variant site in the NFKB2 gene; d Sanger sequencing in NFKB2. CRP: C-reactive protein; EOS: Eosinophils; WBC: white blood cell

Back to article page